Blog
Novo Nordisk: CagriSema Underwhelms In REDEFINE-1 Trial
Novo Nordisk: CagriSema Underwhelms In REDEFINE-1 Trial #Novo #Nordisk #CagriSema #Underwhelms #REDEFINE1 #Trial
ChatGPT and Generative AI: What They Mean for Investment Professionals
For more on artificial intelligence (AI) applications in investment management, read The Handbook of Artificial Intelligence and…
Rivian executives accused of harassment in previously unreported lawsuits
Four employees have sued Rivian in separate lawsuits this year over allegations they were harassed, in…
Amesite Stock Soars to 52-Week High, Hits $4.62 By Investing.com
Amesite Operating Co. (AMST) stock has reached a new 52-week high, climbing to $4.62, marking a…
Winnebago Industries, Inc. 2025 Q1 – Results – Earnings Call Presentation (NYSE:WGO)
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of…
‘Genius Girl’ goes from inspiring a Korean TV show character to raising a $100 million AI fund
On the weekend, as most students were stumbling back from the bars, Songyee Yoon was rushing…
Regret and Optimal Portfolio Allocations
How is risk defined in portfolio optimization objective functions? Usually with a volatility metric, and often…
Nasdaq extension, new tech collaboration, and FDA approval set tone for pre-market
& CEIFX Good day, 360! HEADS UP: JW is having an Open House TODAY in Market…
Nozomi Energy completes largest acquisition to date
Nozomi Energy, a Japan-focused renewables platform established by global sustainable infrastructure investor Actis, has announced its…
Why Apple sends spyware victims to this nonprofit security lab
Before the elections, the cybersecurity team of U.S. vice president and then-presidential candidate Kamala Harris reached…
Distress Investing: A Tale of Two Case Studies
With recession forecasted in many economies this year or next, distressed situations will be an important…
Monopar Therapeutics sets stock and warrant offering prices By Investing.com
WILMETTE, Ill. – Monopar Therapeutics Inc . (NASDAQ:), a clinical-stage biopharmaceutical company whose stock has surged…
7 Upcoming Dividend Increases | Seeking Alpha
This article was written by Follow Derek is an individual investor seeking to navigate the investment…
Energy Revolution Ventures’ $18M fund lays a bet on ‘new chemistry’ startups in energy and hydrogen
What happens when a chemical engineer, who’s previously built a hydrogen-powered drone, becomes a venture capitalist?…
Restrictive trade and immigration policies to help delay further rate cuts: MS By Investing.com
Investing.com — The Federal Reserve’s stance on interest rate cuts has shifted, with restrictive trade and immigration…
My Highest Conviction REIT Investment Idea: Big Yellow Group (OTCMKTS:BYLOF)
This article was written by Follow Jussi Askola is the President of Leonberg Capital, a value-oriented…
Government review of denied datacentre builds sees Iver project get green light
A government review of a local council’s decision to block a US-based company from building…
Microstrategy, other bitcoin-linked stocks slip as crypto market cools off By Investing.com
Investing.com — Shares of companies with significant cryptocurrency exposure, including Microstrategy, Inc. (NASDAQ: NASDAQ:), Marathon Digital…
Radware: A Cheaply Valued Cybersecurity Leader
Radware: A Cheaply Valued Cybersecurity Leader #Radware #Cheaply #Valued #Cybersecurity #Leader
Editor’s Picks: Top 3 Book Reviews of 2024 and a Sneak Peek at 2025
The brief descriptions below are of my three favorites among the book reviews published in 2024…
Lazard Emerging Markets Equity Advantage Portfolio Q3 2024 Commentary (Mutual Fund:READX)
This article was written by Follow Lazard Asset Management is known for its global perspective on…